Estimating the private benefits of vaccination against cholera in Beira, Mozambique: A travel cost approach

Journal of Development Economics

Volumn 91, Issue 2, 2010, Pages 310-322

  Jeuland, Marc ^c   Lucas, Marcelino ^a   Clemens, John ^b   Whittington, Dale ^c,d  

^a Ministry of Science and Technology   (Mozambique)

^b International Vaccine Institute   (South Korea)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cholera; Mozambique; Travel cost; Vaccine demand; Willingness to pay

Indexed keywords

CHOLERA; COST-BENEFIT ANALYSIS; ESTIMATION METHOD; NUMERICAL MODEL; SENSITIVITY ANALYSIS; VACCINATION; VACCINE; WILLINGNESS TO PAY;

AFRICA; BEIRA; MOZAMBIQUE; SOFALA; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

DORCATRAGUS MEGALOTIS;

EID: 70350765006     PISSN: 03043878     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdeveco.2009.06.007     Document Type: Article

References (33)

1. Brookshire D.S. Valuing public goods: a comparison of survey and hedonic approaches. American Economic Review 72 1 (1982) 165-177
2. Brown R.W., and Jewell R.T. County-level alcohol availability and cirrhosis mortality. Eastern Economic Journal 22 3 (1996) 291
3. Cameron T.A. Combining contingent valuation and travel cost data for the valuation of nonmarket goods. Land Economics 68 3 (1992) 302-317
4. Canh D.G., Whittington D., Thoa L.T.K., Utomo N., Hoa N.T., Poulos C., Thuy D.T.D., Kim D., and Nyamete A. Household demand for typhoid fever vaccines in Hue City, Vietnam. Health Policy and Planning 21 (2006) 241-255
5. Carson R.T. Contingent valuation and revealed preference methodologies: comparing the estimates for quasi-public goods. Land Economics 72 1 (1996) 80-99
6. Clarke P.M. Cost-benefit analysis and mammographic screening: a travel cost approach. Journal of Health Economics 17 6 (1998) 767-787
7. Clarke P.M. Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care. Health Economics 11 2 (2002) 117-127
8. Cook J., Whittington D., Canh D.G., Johnson F.R., and Nyamete A. Reliability of stated preferences for cholera and typhoid vaccines with time to think in Hue, Vietnam. Economic Inquiry 45 1 (2007) 100-114
9. Cook, J., Jeuland, M., Whittington, D., Poulos, C., Clemens, J., Sur, D., Anh, D., Agtinih, M., Bhuttai, Z., DOMI Typhoid Economics Study Group, 2008a. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. Vaccine 26 (50), 6305-6316.
10. Cook, J., Jeuland, M., Maskery, B., Lauria, D., Sur, D., Clemens, J., Whittington, D, 2008b. Using private demand studies to calculate socially-optimal vaccine subsidies in developing countries. Journal of Policy Analysis and Management 28 (1), 6-28.
11. Cropper M.L., Haile M., Lampietti J., Poulos C., and Whittington D. The demand for a malaria vaccine: evidence from Ethiopia. Journal of Development Economics 75 1 (2004) 303-318
12. Englin J., and Shonkwiler J.S. Modeling recreation demand in the presence of unobservable travel costs: toward a travel price model. Journal of Environmental Economics and Management 29 3 (1995) 368-377
13. Fischer T.K., Anh D.D., Antil L., Cat N.D.L., Kilgore P.E., Thiem V.D., Rheingans R., Tho L.H., Glass R.I., and Bresee J.S. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. Journal of Infectious Diseases 192 10 (2005) 1720-1727
14. Freeman III A.M. The measurement of environmental and resource values: theory and methods (2003), Resources for the Future, Washington, D.C.
15. Haab, T.C., & McConnell, K.E. Valuing environmental and natural resources: the econometrics of non-market valuation Cheltenham, U.K. and Northampton, Mass.: Elgar; distributed by American International Distribution Corporation, Williston, Vt; 2002.
16. Harris K.M., and Keane M.P. A model of health plan choice: inferring preferences and perceptions from a combination of revealed preference and attitudinal data. Journal of Econometrics 89 1-2 (1999) 131-157
17. Harris K., Schultz J., and Feldman R. Measuring consumer perceptions of quality differences among competing health benefit plans. Journal of Health Economics 21 1 (2002) 1-17
18. Instituti Nacional de Estatística. Second National Census (1998) Government of Mozambique: Maputo
19. Jefferson T. Do vaccines make best use of available resources? (In other words are they cost effective?). Vaccine 17 (1998) 69-73
20. Jeuland, M., Whittington, D., 2009. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs. Vaccine 27 (23), 3109-3120.
21. Jeuland M., Lucas M., Clemens J., and Whittington D. A Cost-Benefit Analysis of Cholera Vaccination Programs in Beira, Mozambique. World Bank Economic Review 23 2 (2009) 235-267
22. Kim, D., Canh, D.G., Poulos, C., Thoa, L.T.K., Cook, J., Hoa, N.T., Nyamete, A., Thuy, D.T.D., Deen, J., Trach, D.D., Clemens, J., Thiem, V.D., Anh, D.D., Whittington, D, 2007. Private demand for cholera vaccines in Hue, Vietnam. Value in Health 11 (1), 119-128.
23. Kling C.L. The gains from combining travel cost and contingent valuation data to value nonmarket goods. Land Economics 73 3 (1997) 428-439
24. Leonard K.L., Mliga G.R., and Mariam D.H. Bypassing health centres in Tanzania: revealed preferences for quality. Journal of African Economies 11 4 (2002) 441-471
25. Lucas M., Deen J.L., Von Seidlein L., Wang X.-Y., Ampuero J., Puri M., Ali M., Ansaruzzaman M., Amos J., Macuamule A., Cavailler P., Guerin P.J., Mahoudeau C., Kahozi-Sangwa P., Chaignat C.-L., Barreto A., Songane F.F., and Clemens J.D. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. New England Journal of Medicine 352 8 (2005) 757-767
26. Lucas M., Jeuland M., Deen J., Lazaro N., MacMahon M., Nyamete A., Barreto A., Seidlein L.v., Cumbane A., Songane F.F., and Whittington D. Private demand for cholera vaccines in Beira, Mozambique. Vaccine 25 14 (2006) 2599-2609
27. Mackie P.J., Jara-Diaz S., and Fowkes A.S. The value of travel time savings in evaluation. Transportation Research: Part E: Logistics and Transportation Review 37 2-3 (2001) 91-106
28. Shaw W.D., and Feather P. Possibilities for including the opportunity cost of time in recreation demand systems. Land Economics 75 4 (1999) 592-602
29. Thiem V.D., Hossain M.M., Son N.D., Hoa N.T., Rao M.R., et al. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. Journal of Health Population and Nutrition 21 4 (2003) 304-308
30. Wang'ombe J.K. Economic evaluation in primary health care: the case of Western Kenya community based health care project. Social Science and Medicine 18 5 (1984) 375-385
31. Whittington D., Matsui-Santana O., Freiberger J.J., Van Houtven G., and Pattanayak S. Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico. Vaccine 20 19/20 (2002) 2585-2591
32. Whittington, D., Sur, D., Cook, J., Chatterjee, S., Maskery, B., Lahiri, M., Poulos, C., Boral, S., Nyamete, A., Deen, J., Ochiai, L., Bhattacharya, S., 2009. Rethinking cholera and typhoid vaccination policies for the poor: private demand in Kolkata, India. World Development 37 (2), 399-409.
33. WHO. Mozambique mass campaign tests the theory: vaccines could limit the impact of cholera. WHO Week in Review (2004)